CoreWeave, Inc. Class A Common Stock
CRWV
$82.24
+4.84%
CoreWeave is a modern cloud infrastructure technology company operating in the Software - Infrastructure industry. It is a specialized AI infrastructure provider, leveraging its proprietary platform to manage complex AI workloads at scale.
CRWV
CoreWeave, Inc. Class A Common Stock
$82.24
Related headlines
Investment Opinion: Should I buy CRWV Today?
Synthesized Analyst Rating: Hold. The explosive growth potential is undeniable, but it is counterbalanced by severe financial risk and a lack of profitability. The stock is suitable only for investors with a very high risk tolerance and a long-term horizon who can withstand extreme volatility. The current valuation, while rich on a sales multiple basis, prices in tremendous future success that is far from certain. Investors should wait for more clarity on the path to sustainable profitability and improved balance sheet health before establishing a significant position.
Sign up to view all
CRWV 12-Month Price Forecast
The investment thesis is a binary bet on growth versus financial sustainability. The 12-month outlook is highly uncertain, with a wide range of potential outcomes centered on volatile, range-bound trading as the market awaits clearer signs of a path to profitability.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CoreWeave, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $106.91 and implied upside of +30.0% versus the current price.
Average Target
$106.91
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$66 - $107
Analyst target range
Wall Street analyst coverage consists of 6 analysts, with recent institutional ratings showing a mix of Buy, Outperform, and Hold recommendations from firms like Citigroup, Evercore ISI, and Mizuho. Consensus estimates point to significant future growth, with average revenue expectations of $75.64 billion and average EPS estimates of $8.88. The wide range between low and high revenue estimates ($62.53B to $86.60B) indicates uncertainty around the scale and timing of this growth trajectory.
Bulls vs Bears: CRWV Investment Factors
CoreWeave presents a classic high-risk, high-reward growth story. The company is capitalizing on the AI infrastructure boom with triple-digit revenue growth and strong gross margins. However, this growth is fueled by massive capital investment and debt, resulting in deep losses and a precarious financial position. The stock's extreme volatility reflects the binary bet on its ability to achieve profitability at scale.
Bullish
- Explosive Revenue Growth: Revenue grew 110% YoY, demonstrating strong market demand.
- Dominant AI Infrastructure Position: Specialized platform for complex AI workloads at scale.
- Strong Gross Margin: Healthy gross margin of 67.6% indicates solid core profitability.
- Massive Analyst Growth Forecast: Average revenue estimate of $75.6B implies massive future scale.
Bearish
- Severe Lack of Profitability: Net margin of -28.7% and deeply negative EPS.
- Extremely High Financial Leverage: Debt-to-equity ratio of 4.54 signals high bankruptcy risk.
- Weak Liquidity Position: Current ratio of 0.46 indicates potential short-term liquidity strain.
- Massive Capital Expenditure Burn: Free cash flow TTM is -$7.25B due to heavy infrastructure spend.
CRWV Technical Analysis
The stock has experienced significant volatility over the past six months, declining 43.86% from its price six months ago. However, it has shown relative strength recently, gaining 8.18% over the last three months and 12.03% from its previous close of $69.15 to the current price of $77.47, outperforming the broader market (SPY) which fell 4.63% over the same three-month period. In the short term, the stock is down 2.63% over the past month, but this still represents a relative strength of +2.62 compared to the SPY's 5.25% decline. The price action shows a recovery from a low near $69 in late March, though it remains volatile with a 52-week range of $33.52 to $187. The current price of $77.47 sits approximately 58.5% above its 52-week low but remains 58.6% below its 52-week high, indicating it is in the lower half of its yearly range. The stock has experienced a maximum drawdown of -64.84%, reflecting the high volatility inherent in its trading pattern.
Beta
—
—
Max Drawdown
-64.8%
Largest decline past year
52-Week Range
$34-$187
Price range past year
Annual Return
+34.0%
Cumulative gain past year
| Period | CRWV Return | S&P 500 |
|---|---|---|
| 1m | +11.5% | -3.6% |
| 3m | +3.7% | -4.0% |
| 6m | -39.0% | -2.0% |
| 1y | +34.0% | +16.2% |
| ytd | +3.7% | -3.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRWV Fundamental Analysis
Revenue growth is explosive, with a year-over-year increase of 110.3% for the quarter ending December 31, 2025, reaching $1.57 billion. However, profitability remains a major challenge, as the company reported a net loss of $451.7 million for the same quarter, translating to a net margin of -28.7%. The gross margin is healthy at 67.6%, but operating expenses and significant interest costs drive deep losses. Financial health is concerning, with a debt-to-equity ratio of 4.54, indicating high leverage. The current ratio is weak at 0.46, suggesting potential liquidity strain. Cash flow from operations was positive at $1.56 billion for the latest quarter, but free cash flow was deeply negative at -$7.25 billion (TTM) due to massive capital expenditures for infrastructure build-out. Operational efficiency metrics are poor due to losses. Return on Equity (ROE) is deeply negative at -34.99%, and Return on Assets (ROA) is -0.03%. The high debt load and ongoing losses significantly impair capital efficiency, though the company is prioritizing growth and scale over current profitability.
Quarterly Revenue
$1.6B
2025-12
Revenue YoY Growth
+1.10%
YoY Comparison
Gross Margin
+0.67%
Latest Quarter
Free Cash Flow
$-7.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRWV Overvalued?
Given the company's negative net income, the Price-to-Sales (PS) ratio is the primary valuation metric, which stands at 6.07. The Enterprise Value-to-Sales (EV/Sales) ratio is 13.13, reflecting the market's incorporation of the company's substantial debt into its valuation. These multiples are typical for a high-growth, pre-profitability company in a capital-intensive sector. Peer comparison data is not available in the provided inputs. The valuation appears to be pricing in significant future growth, as evidenced by the forward-looking analyst revenue estimates averaging $75.64 billion, which is many times the current run-rate. The negative PEG ratio of -1.48 is not meaningful due to the lack of positive earnings growth.
PE
-26.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -155x~-12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.2x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is financial: the company's high leverage (debt-to-equity of 4.54) and weak liquidity (current ratio of 0.46) create significant solvency and refinancing risk, especially in a higher interest rate environment. The business model is capital-intensive, as evidenced by the -$7.25 billion TTM free cash flow burn, requiring continuous access to capital markets. Execution risk is high, as the company must successfully scale operations to meet analyst revenue forecasts averaging $75.64 billion, a monumental leap from the current ~$1.6 billion quarterly run-rate. Market and competitive risks are also substantial. The stock has shown extreme volatility with a -64.84% maximum drawdown, indicating high sensitivity to sentiment shifts in the AI sector. Recent news highlights large, competitive deals in the neocloud space (e.g., Nebius's $49B contracts), signaling intense competition for long-term AI infrastructure contracts. The company's path to profitability is unproven, and any slowdown in AI investment or failure to convert revenue growth into net income could lead to a severe de-rating of its valuation multiples.